| 朱雪莲 鲁利民 朱锦萍 金辉 孟静.丹参酮ⅡA 磺酸钠注射液对原发性高血压患者血脂水平及内皮功能的影响[J].现代生物医学进展英文版,2016,16(20):3932-3935. |
| 丹参酮ⅡA 磺酸钠注射液对原发性高血压患者血脂水平及内皮功能的影响 |
| Effect of SodiumTanshinone IIA Sulfonate Injection on the Blood LipidLevel and Endothelial Function of Patients with Primary Hypertension |
| |
| DOI： |
| 中文关键词: 原发性高血压 丹参酮ⅡA 血脂 内皮功能 |
| 英文关键词: Hypertension Tanshinone A Blood lipid Endothelial function |
| 基金项目:北京市自然科学基金项目(7072032) |
|
| Hits: 602 |
| Download times: 0 |
| 中文摘要: |
| 目的：研究丹参酮ⅡA磺酸钠注射液对原发性高血压患者血脂水平及内皮功能的影响。方法：选择2013 年5 月-2015 年10
月在我院首次诊断为原发性高血压的80 例患者作为研究对象，根据治疗方法不同将入组患者随机分为实验组和对照组。实验组
患者接受丹参酮ⅡA 磺酸钠注射液联合口服降压药物治疗，对照组患者仅接受口服降压药物治疗，比较两者患者治疗前后的血
压、肝肾功能、血脂水平以及内皮功能指标的变化。结果：治疗后，两组患者的收缩压、舒张压水平均低于治疗前，且实验组患者的
收缩压、舒张压水平与对照组比较均无统计学差异。治疗后，两组患者的ALT、AST、Scr水平均与治疗前比较均无显著差异，且实
验组患者的ALT、AST、Scr水平与对照组比较无统计学差异。治疗后，实验组患者的TC、TG、LDL 水平明显低于治疗前(P<0.05)，
对照组患者的TC、TG、LDL与治疗前比较无统计学差异(P>0.05)，实验组患者的TC、TG、LDL 水平显著低于对照组(P<0.05)。结
论：丹参酮ⅡA 磺酸钠注射液有助于改善原发性高血压患者的血脂代谢以及内皮功能，且对患者的肝肾功能无明显影响。 |
| 英文摘要: |
| Objective:To study the effect of sodium tanshinone IIA sulfonate injection on blood lipid level and endothelial
function of patients with primary hypertension.Methods:80 patients first diagnosed as primary hypertension in our hospital from May
2013 to October 2015 were collected as the research object and randomly divided into the experimental group and control group
according to different treatment methods. The patients in experimental group received tanshinone IIA sulfonate injection combined with
oral antihypertensive drug therapy, patients in the control group only received oral antihypertensive drug therapy. Then the changes of
blood pressure levels, liver and kidney function, blood lipid levels and endothelial function of two groups before and after treatment were
compared.Results:After the treatment, the systolic blood pressure, diastolic blood pressure levels of both groups were lower than those
before treatment and the systolic blood pressure, diastolic blood pressure levels of experimental group had no significant difference
compared with the control group (P>0.05); after treatment, the ALT, AST, SCR contents of both groups had no significant difference
compared with those before treatment and the ALT, AST, SCR contents of experimental group had no statistical difference compared
with the control group (P>0.05); after treatment, the TC, TG, LDL levels of experimental group were significantly lower than those of
control group (P<0.05).Conclusion:Tanshinone II A sodiuminjection was helpful to improve the blood lipid metabolismand endothelial
function of patients with primary hypertension and had positive clinical application value. |
|
View Full Text
View/Add Comment Download reader |
| Close |
